To ensure compliance with Electronic Prescribing of Controlled Substances (EPCS), healthcare providers can turn to IdenTrust’s one-stop solution for streamlined identity-proofing and multi-factor authentication. With the rise of e-prescribing legislation and the opioid crisis,…
Continue Reading
Welcome to the exciting world of digital health startups! In this video, we’ll walk you through the key regulations you need to know to thrive in this fast-paced industry without getting bogged down in…
Continue Reading
This is a developing story with updates expected.U.S. Senators Mark Warner (D-Va.), John Thune (R-S.D.) and four of their colleagues expressed support for the Drug Enforcement Administration’s new engagement on a potential special registration…
Continue Reading
As the Drug Enforcement Administration (DEA) holds listening sessions this week for its proposed rule that rolls back Covid-19 flexibilities for the virtual prescribing of controlled substances, four mental health companies issued a letter…
Continue Reading
The DEA’s potential introduction of a telehealth-controlled substance registry is lauded by the American Telemedicine Association (ATA). The DEA’s upcoming listening sessions aim to explore the feasibility of remote prescribing of essential controlled substances…
Continue Reading
The American Telemedicine Association released a statement on Friday saying that it applauds the Drug Enforcement Agency for posting a meeting notice on Friday that indicates that it is “openly considering” a special registration that would…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
The DEA and SAMHSA have extended telehealth prescribing flexibilities for controlled substances through November 11, 2024, following a temporary rule. The move comes after several healthcare organizations, including the AHA, requested continued telehealth prescribing…
Continue Reading
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…
By Mark Melchionna
April 26, 2023 – Published in Health Affairs, a new viewpoint article emphasized the prevalence of opioid use disorder (OUD)-related deaths and how regulatory actions are needed to ensure access to virtual…
Continue Reading
